about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
4.94
0.54
(12.27%)
50,092.9
XNAS Volume
XNAS 22 Sep, 2026 11:53 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..